Bioteque Corporation (4107) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bioteque Corporation (4107:TWSE), powered by AI.

Current Price
$116.50
Sector
Healthcare
What is the Bioteque Corporation stock price forecast?

Bioteque Corporation is currently trading at $116.50. View real-time AI analysis on Alpha Lenz.

What is Bioteque Corporation insider trading activity?

View the latest insider trading data for Bioteque Corporation on Alpha Lenz.

What is Bioteque Corporation's P/E ratio?

View Bioteque Corporation's valuation metrics on Alpha Lenz.

Bioteque Corporation

TWSE · 4107
NT$116.50-1.50(-1.27%)
Ask about Bioteque Corporation's future dividend policy...
Alpha Chat Insight

Bioteque Corporation's ROE is 15.3%. Explore profitability and growth together.

Ask for details

Company Overview

Bioteque Corporation is a leading Taiwanese manufacturer specializing in medical devices, particularly disposable products essential for hemodialysis access, endovascular treatment, and other healthcare applications. Established in 1991 and headquartered in Taipei, Bioteque serves the global healthcare sector by producing items such as hemodialysis bloodline sets, AV fistula needles, IV infusion bags and sets, surgical drainage tubes, catheters, and a variety of medical components and homecare products. These products are distributed internationally, reaching markets across Asia, Europe, the Americas, and Africa. Renowned for its commitment to quality, the company operates multiple advanced manufacturing facilities accredited under ISO 13485 and compliant with FDA and GMP standards. As a publicly listed entity since 2002, Bioteque Corporation plays a significant role in the health technology industry by supporting hospitals, clinics, and health systems with critical single-use medical solutions and by continually investing in research and development to expand its innovative product portfolio.

SectorHealthcare
IndustryMedical Instruments & Supplies
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$2.14BRevenue
0.00Shares Out
0Employees

Margins

43.88%Gross
39.98%EBITDA
31.39%Operating
31.59%Pre-Tax
25.25%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

2.03%Rev 3Yr
1.86%Rev 5Yr
5.04%Op Inc 3Yr
2.01%Op Inc 5Yr
2.99%Net Inc 3Yr
1.99%Net Inc 5Yr

Returns

11.59%ROA
15.30%ROE
14.66%ROIC

Financial Health

NT$1.16BCash & Cash Equivalents
NT$-107.82MNet Debt
29.19%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Bioteque Corporation (ticker: 4107) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies).

The current price is 116.5 with a P/E ratio of -x and P/B of -x.

ROE is 15.30% and operating margin is 31.39%. Annual revenue is $2.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Bioteque Corporation (4107) Stock Forecast 2026 $116.50 — Price, Financials & Analyst Targets | Alpha Lenz